Urinary proteome analysis enables assessment of renoprotective treatment in type 2 diabetic patients with microalbuminuria

BACKGROUND: Previously the angiotensin II receptor blocker Irbesartan has been demonstrated to reduce the risk for progression from microalbuminuria to macroalbuminuria in type 2 diabetic patients. The purpose of this study was to evaluate the effect of treatment with Irbesartan in type 2 diabetic p...

Descripción completa

Detalles Bibliográficos
Autores principales: Andersen, Sten, Mischak, Harald, Zürbig, Petra, Parving, Hans-Henrik, Rossing, Peter
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2988775/
https://www.ncbi.nlm.nih.gov/pubmed/21040538
http://dx.doi.org/10.1186/1471-2369-11-29

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2988775/
https://www.ncbi.nlm.nih.gov/pubmed/21040538
http://dx.doi.org/10.1186/1471-2369-11-29

Ejemplares similares